SARCOIDOSIS
Clinical trials for SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart procedure may beat drugs for deadly rhythm disorder
Disease control OngoingThis study compares two treatments for ventricular tachycardia (VT), a fast heart rhythm that can be life-threatening, in people with structural heart disease. About 162 participants will either get a catheter ablation (a procedure to destroy the tiny area causing the problem) or…
Matched conditions: SARCOIDOSIS
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
Sarcoidosis drug dilemma: stop or stay?
Disease control OngoingThis study looks at whether people with sarcoidosis who are in remission should stop taking the drug infliximab or continue it to prevent the disease from coming back. The trial involves 32 adults who have been on infliximab for at least 6 months and are currently stable. Researc…
Matched conditions: SARCOIDOSIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Can exercise at home help lung disease patients breathe easier?
Symptom relief OngoingThis pilot study tests whether home-based or supervised online exercise programs are acceptable and helpful for people with chronic lung diseases like IPF, sarcoidosis, bronchiectasis, and asthma. About 50 participants will be randomly assigned to one of three groups: group onlin…
Matched conditions: SARCOIDOSIS
Phase: NA • Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Symptom relief
Last updated May 17, 2026 04:13 UTC
-
Does taking your sarcoidosis meds on time really matter? this study finds out.
Knowledge-focused OngoingThis study looks at how well people with sarcoidosis follow their medication routine and how that affects their disease. Researchers will follow 150 adults in Maryland and D.C. for one year, tracking lung function, symptoms, and hospital visits. The goal is to understand barriers…
Matched conditions: SARCOIDOSIS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC